Victory Capital Management Inc Hoth Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.53 - $4.08 $2,039 - $3,288	-806 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.62 - $6.59 $49 - $125	-19 Reduced 2.3%	806 $2,000
Q4 2019 Feb 04, 2020	BUY	$3.34 - $6.19 $410 - $761	123 Added 17.52%	825 $4,000
Q3 2019 Nov 12, 2019	BUY	$4.25 - $7.18 $2,983 - $5,040	702 New	702 $3,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.